• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC SWITZERLAND GMBH CENTRIMAG BLOOD PUMP; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC SWITZERLAND GMBH CENTRIMAG BLOOD PUMP; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 102953
Device Problems Mechanical Problem (1384); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Renal Failure (2041); Multiple Organ Failure (3261); Thrombosis/Thrombus (4440); Heart Failure/Congestive Heart Failure (4446)
Event Date 10/15/2023
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient had multiple right ventricular assist device (rvad) placements, clotting, and kidney dysfunction.The kidney dysfunction was not device related.It was treated with continuous venovenous hemodiafiltration (cvvhd).The right heart failure developed after pump implantation.It was not device related.There were 2 rvad placements performed, one to wean off, and another due to right ventricular failure exacerbation.A thrombus was found in the pump of the rvad, so it was discontinued.The patient eventually passed away due to multisystem organ failure.The pump operated as expected and the outcome was not device or therapy related.Related lvad manufacturer report number: 2916596-2024-00686.
 
Event Description
It was reported that on (b)(6) 2023, the patient had their heartmate ii pump exchanged to a heartmate 3 pump, with right ventricular assist device (rvad) for support.It was noted that the patient was stable post exchange; however, additional information revealed that the patient had multiple rvad placements, clotting, and kidney dysfunction.The kidney dysfunction was reportedly not device related and was treated with continuous venovenous hemodiafiltration.The right heart failure developed after pump implantation; however, it was not thought to be device related.There were 2 rvad placements performed, one to wean off, and another due to right ventricular failure exacerbation.A thrombus was found in the pump of the rvad, so it was discontinued.The patient eventually passed away on (b)(6) 2024 due to multi-system organ failure.It was noted that the device operated as expected and the outcome was not considered device or therapy related.Related manufacturer report numbers: 2916596-2023-07443 and 2916596-2024-00686.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: clotting was unable to be confirmed as the device was not returned for evaluation, and no photos were submitted.A direct correlation between the reported events and the centrimag blood pump could not be conclusively established through this evaluation.The centrimag blood pump was not returned for evaluation.The united states centrimag blood pump instructions for use (ifu) (rev.C) lists potential adverse events that may be associated with the use of the centrimag blood pump, including venous thromboembolism, arterial non-cns (non-central nervous system) thromboembolism, death, and multiple types of organ failure and dysfunction (hepatic dysfunction, renal failure/dysfunction, respiratory failure, and right heart failure).The ifu contains the following additional warnings and cautions: ifu warning #7: it is intended that systemic anticoagulation be utilized while this device is in use.Anticoagulation levels should be determined by the physician based on risks and benefits to the patient.Ifu warning #10: frequent patient and device monitoring is recommended.Ifu caution #2: this device should only be used by persons thoroughly trained in extracorporeal circulation procedures.Ifu caution #9: monitor carefully for any signs of occlusion throughout the circuit.Ifu caution #15: always have a backup centrimag pump, console, motor, and accessories available for use.The lot number or other identifying information of the product was not reported and was not able to be determined during the investigation.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRIMAG BLOOD PUMP
Type of Device
CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
THORATEC SWITZERLAND GMBH
technoparkstrasse 1
zurich CH-80 05
SZ  CH-8005
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key18687280
MDR Text Key335193715
Report Number3003306248-2024-00399
Device Sequence Number1
Product Code KFM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K020271
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/29/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received02/12/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number102953
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age28 YR
Patient SexMale
Patient Weight132 KG
-
-